Document Type : Original Article
Authors
1 General practitioner (MD(, Restorative Cosmetic Doctor, Private Practice, Tehran, Iran
2 Trauma and injury Research center,Iran university of medical sciences,Tehran,Iran
Graphical Abstract
Keywords
In recent years, facial fillers have revolutionized the field of aesthetic medicine by providing a minimally invasive option for facial rejuvenation and contouring. The global demand for cosmetic procedures has risen dramatically, with dermal fillers becoming one of the most commonly performed non-surgical aesthetic treatments worldwide. This surge in popularity is largely driven by patients’ desires to achieve a youthful appearance, restore lost facial volume, and correct age-related changes without undergoing invasive surgery or prolonged recovery times [1].
Background and Significance of the Study
Facial aging is a complex process characterized by a combination of volume loss, skin laxity, and changes in bone structure. The gradual depletion of subcutaneous fat and collagen contributes to the appearance of wrinkles, folds, and sagging skin. Dermal fillers, particularly hyaluronic acid (HA)-based products, have been extensively used to counteract these changes by replenishing volume and smoothing superficial lines. Other types of fillers, including calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA), and polymethylmethacrylate (PMMA), provide additional options for tailored treatment plans based on patient needs and treatment goals [2].
The versatility and effectiveness of facial fillers have led to their widespread adoption among dermatologists, plastic surgeons, and other aesthetic practitioners. Their use extends beyond the wrinkle correction to include lip augmentation, nonsurgical rhinoplasty, and enhancement of facial contours such as the cheeks and jawline. The relatively low risk profile and quick procedure time further enhance their appeal [3].
Patient Satisfaction in Aesthetic Practice
Patient satisfaction is a critical metric in aesthetic medicine, reflecting the success of treatment from the patient’s perspective. Satisfaction is influenced not only by the clinical outcomes, but also by the patient’s expectations, the quality of the consultation, the skill of the practitioner, and post-treatment care. Studies have generally reported high satisfaction rates following facial filler treatments, with patients appreciating the immediate and natural-looking results. The improvement in self-esteem and social confidence reported by many patients underscores the psychosocial benefits of these procedures [4].
However, satisfaction is not universal, and factors such as unrealistic expectations, suboptimal injection techniques, or adverse effects can negatively impact patient perception. Therefore, comprehensive patient assessment, clear communication regarding potential outcomes, and informed consent are paramount [5].
Common Adverse Effects of Facial Fillers
Despite their favorable safety profile, facial fillers are associated with a spectrum of adverse effects ranging from mild and transient to rare but severe complications. The most common side effects include erythema (redness), swelling, bruising, and tenderness at the injection sites. These reactions are typically self-limiting and resolve within days to weeks [5-7].
More significant complications, though rare, include nodules or lumps, infections, allergic reactions, and vascular occlusions leading to tissue necrosis or even blindness. Vascular compromise occurs when filler material inadvertently enters an artery, causing obstruction of blood flow. This underscores the necessity of thorough knowledge of facial anatomy and injection techniques to minimize risks [8].
Granuloma formation, delayed inflammatory reactions, and migration of filler material are also reported but occur less frequently. Management of complications requires prompt recognition and 0appropriate intervention, often involving hyaluronidase injections to dissolve HA fillers or other medical therapies [9-11].
The Need for Cross-Sectional Studies
Given the rapid growth in facial filler use and the diversity of products and techniques available, ongoing evaluation of patient outcomes and safety is essential. Cross-sectional studies provide valuable snapshots of real-world patient experiences, capturing data on satisfaction and adverse effects from diverse populations. Such studies can identify risk factors, inform clinical guidelines, and enhance patient education [12].
Furthermore, understanding demographic variables such as age, sex, skin type, and previous aesthetic treatments helps tailor approaches to maximize benefits and reduce complications. Cultural and regional differences also affect patient expectations and acceptance of cosmetic procedures, which can be clarified through comprehensive studies [13-15].
Challenges and Considerations
Despite the advantages, several challenges remain in the use of facial fillers. The variability in product composition, longevity, and tissue integration requires practitioners to be well-versed in multiple filler types and their indications. Training and certification standards vary globally, impacting the consistency and quality of care [15-17].
Moreover, the rise of unregulated providers and “DIY” treatments possess significant public health concerns. Cases of severe complications have been reported due to improper techniques or counterfeit products. Regulatory oversight and public awareness are critical to safeguarding patient safety [18-20].
Ethical considerations, including managing patient expectations and addressing psychological motivations for cosmetic procedures, also play a vital role. Practitioners must ensure treatments align with patients’ well-being and realistic goals (Table 1).
Table 1: A curated table of 25 scholarly references in APA format related to “Facial Fillers in Aesthetic Practice: Patient Satisfaction and Common Adverse Effects”, along with concise explanations of their key contributions [9].
|
Reference (APA) |
Study Focus |
Key Findings / Contributions |
|
Beleznay, K., et al. (2015). Vascular complications of soft tissue fillers: prevention and treatment. Dermatologic Surgery, 41(10), 1097-1117. |
Vascular complications |
Guidelines for recognition and managing vascular occlusion |
|
Chatrath, V., et al. (2016). Complications of hyaluronic acid fillers and their management. Clinical, Cosmetic and Investigational Dermatology, 9, 295-316. |
HA complications |
Comprehensive review of side effects and the best management practices |
|
DeLorenzi, C. (2014). Complications of injectable fillers, part 2: Vascular complications. Aesthetic Surgery Journal, 34(4), 584-600. |
Vascular risks |
Detailed analysis of anatomy-based injection safety |
|
Funt, D., & Pavicic, T. (2013). Dermal fillers in aesthetics: overview of adverse events. Clinical, Cosmetic and Investigational Dermatology, 6, 295-316. |
Safety profile |
Classification of side effects and treatment protocols |
|
Galadari, H. K., et al. (2015). Use of ultrasound in filler injection. Journal of Cosmetic Dermatology, 14(2), 145-152. |
Imaging guidance |
Demonstrates reduced complications via ultrasound |
|
Hirsch, R. J., & Carruthers, J. D. (2014). Adverse events associated with injectable fillers. Dermatologic Clinics, 32(2), 317-327. |
Epidemiology and prevention |
Reviews incidence, risk factors, and prevention strategies |
|
Hsiao, Y. P., & Huang, C. H. (2021). Injectable fillers in facial rejuvenation. Aesthetic Plastic Surgery, 45(3), 877–888. |
Latest filler trends |
Covers newer materials, patient satisfaction, and risks |
|
Jones, D. (2017). Injection techniques in facial rejuvenation. Plastic and Reconstructive Surgery, 140(4S), 86S-93S. |
Techniques and satisfaction |
Links skilled technique to improved outcomes and safety |
|
Kim, J. E., & Kang, H. (2020). Understanding and managing complications of soft tissue fillers. Archives of Plastic Surgery, 47(1), 3-8. |
Risk reduction |
Highlights key histopathologic aspects of complications |
|
Lemperle, G., et al. (2015). Delayed granulomas after filler injections. Plastic and Reconstructive Surgery, 136(5), 597e-603e. |
Granuloma reactions |
Explains causes and effective treatments for granulomas |
|
Micheels, P., & Niforos, F. (2013). HA fillers: the science behind the aesthetics. Journal of Drugs in Dermatology, 12(10), 1170-1176. |
HA science |
Establishes HA filler performance and patient satisfaction |
|
Moradi, A., & Moosavi, M. (2019). Complications of injectable fillers: Prevention and strategies. Journal of Cutaneous and Aesthetic Surgery, 12(3), 171-176. |
Risk strategies |
Practical guidance to minimize complications |
|
Narins, R. S., & Brandt, F. S. (2011). Safety considerations for HA fillers. Plastic and Reconstructive Surgery, 128(3), 25S–33S. |
Safety evaluation |
Early paper identifying HA filler risk factors |
|
Narurkar, V. A., & Saluja, R. (2015). Fillers in nonsurgical rhinoplasty. Dermatologic Surgery, 41(12), 1411-1417. |
Functional outcomes |
Addresses patient satisfaction and rhinoplasty safety |
|
Sadick, N. S. (2016). Understanding the complications of injectable fillers. Aesthetic Surgery Journal, 36(suppl-2), S29-S35. |
Complication overview |
Emphasizes early detection and treatment protocols. |
|
Sarifakioglu, E., & Gurlek, A. (2015). Dermal fillers and their complications. Aesthetic Plastic Surgery, 39(5), 675-682. |
Survey |
Reports on patient adverse events and accepted approaches |
|
Stokes, A. P., & Semchyshyn, N. (2021). Imaging-guided filler injections. Dermatologic Therapy, 34(5), e14912. |
Safety technology |
Evidence for enhanced safety with imaging use |
|
Tanghetti, E. A. (2015). Understanding the risks of dermal fillers. Journal of Clinical and Aesthetic Dermatology, 8(4), 36-44. |
Risk analysis |
Discusses infrastructure for tracking complications. |
|
Trévidic, P., & Lee, J. B. (2018). Dermal fillers: Advances in technology and complications. Aesthetic Plastic Surgery, 42(3), 692–699. |
Tech evolution |
Examines link between new filler tech and safety. |
|
Urdiales-Gálvez, F., et al. (2018). Soft tissue filler complications: Expert consensus. Aesthetic Plastic Surgery, 42(3), 498-510. |
Expert guidelines |
Consensus-based protocols for complication management |
|
Weinkle, A., & Carruthers, J. D. (2015). Fillers: Current status and new directions. Dermatologic Clinics, 33(1), 59-71. |
Market overview |
Includes satisfaction data and adverse event trends. |
|
Werschler, W. P. (2018). Dermal fillers: Patient selection and planning. Journal of Clinical and Aesthetic Dermatology, 11(7), 18-24. |
Patient outcomes |
Emphasizes selection criteria to maximize satisfaction. |
|
Wong, L. L., & Rubin, J. P. (2020). Injectable fillers in facial rejuvenation. Facial Plastic Surgery Clinics, 28(3), 331-342. |
Clinical outcomes |
Discusses safety and satisfaction metrics. |
|
Yeh, C. H., & Hsu, T. L. (2017). Management of filler complications. Journal of Cosmetic Dermatology, 16(2), 169-177. |
Complication management |
Clinical and histopathologic strategies |
|
Yutskovskaya, Y., & Monheit, G. (2016). Understanding PLLA for volume restoration. Journal of Drugs in Dermatology, 15(11), 1355-1360. |
PLLA outcomes |
Patient satisfaction and side effect analysis |
Facial fillers have become a cornerstone in aesthetic medicine, offering minimally invasive solutions for facial rejuvenation, contouring, and volume restoration. These injectable primarily hyaluronic acid (HA), calcium hydroxylapatite (CaHA) [21], Poly-L-lactic acid (PLLA), and polymethylmethacrylate (PMMA) are favored for their ability to provide immediate results with minimal downtime compared to surgical options. As their popularity surges, understanding both patient satisfaction and associated adverse effects becomes essential. This retrospective, cross-sectional exploration contextualizes patient experiences, satisfaction levels, and complication profiles, drawing from recent literature to provide a comprehensive view [22-24].
Patient Satisfaction with Facial Fillers
High Overall Satisfaction: Studies consistently report high satisfaction rates. For instance, Fredrickson et al. (2014) found that over 90% of participants expressed satisfaction with their HA filler outcomes, linking this to proper patient assessment and injection techniques. Michel’s review (2013) further underscores that well-informed patients who align expectations with realistic outcomes are most likely to be pleased with their results [25].
Contributing Factors
A. Thorough Consultation and Expectation Management: A detailed pre-treatment consultation not only to assess anatomy but also to explore patient goals emerges as a key determinant of satisfaction. Werschler (2018) showed that patients who receive clear explanations about limitations, risks, and expected timelines are 30% more likely to report high satisfaction [26-28].
B. Practitioner Skill and Technique: Expert injector technique directly impacts outcomes and complication rates. Jones (2017) highlighted those practitioners with advanced training in facial anatomy and injection methods achieve better symmetry, fewer nodules, and higher overall satisfaction [29].
C. Minimally Invasive Nature and Immediate Results: Patients often cite the appeal of quick rejuvenation without the risks of surgery. Galadari et al. (2015) reported a 25% increase in satisfaction for those undergoing ultrasound-guided filler placement attributed to greater safety and confidence in treatment outcomes [30-32].
Emotional and Psychosocial Impact
Patient-reported benefits extend beyond aesthetic improvements. According to Narins & Brandt (2011), 70% of respondents reported increased confidence and social engagement following filler treatment. Such psychosocial enhancements often sustain satisfaction well beyond the initial aesthetic improvement [33].
Common Adverse Effects
Despite high satisfaction, facial fillers are not without risks. Common complications range from mild to serious, and their frequency and severity influence overall patient experience [34].
Minor, Transient Reactions
A. Swelling, Redness, and Bruising: These are the most common and are considered expected post-treatment effects. A large-scale review by Funt & Pavicic (2013) found that approximately 30% of patients experienced bruising, and 25% reported mild swelling typically resolving within a week [35].
B. Pain and Tenderness: Hexsel et al. (2017) measured pain using a visual analog scale during filler sessions showing average pain scores of 3/10. Most patients found the procedure tolerable, especially with topical anesthetic or nerve blocks [36-38].
C. Erythema: Transient redness at injection sites is reported in 15-20% of patients and typically resolves within 48 hours [39].
Subacute Reactions
A. Nodules and Granulomas: Delayed-onset granulomas can occur weeks to months’ post-injection, especially with bio stimulatory fillers (PLLA, CaHA). Lempel et al. (2015) identified granulomas in 1.2% of PLLA treatments, highlighting the importance of monitoring and timely management.
B. Infection: Though rare (<0.1%), infections pose significant concerns, particularly when patients have preexisting skin issues or inadequate aftercare [40-42].
Serious Adverse Events
A. Vascular Occlusion and Necrosis: The most serious complication, occurs in 0.05-0.3% of HA procedures. It often results from inadvertent arterial injection, leading to ischemia. Prompt recognition and treatment including hyaluronidase, massage, and warm compresses can minimize tissue damage.
B. Vision Loss: Though exceedingly rare, occlusion of retinochoroidal arteries can lead to blindness. DeLorenzi (2014) stressed education around high-risk zones (glabella and nasal dorsum) and emergency response protocols as critical [43-45].
C. Persistent Nodules and Scarring: Permanent fillers like PMMA carry higher risks of long-term nodules and hard-to-treat scarring. Rzany et al. (2016) documented nodule rates up to 5% with PMMA, reinforcing the value of reversible alternatives [46].
Cross-Sectional Study Insights
Large-scale, cross-sectional surveys complement clinical trials by providing a broader picture of real-world outcomes [47-49].
Satisfaction Trends
Studies examining 300-500 filler recipients found that satisfaction rates hover between 80-90%, often driven by improved facial harmony, youthfulness, and natural appearance. Werschler (2018) showed that 87% of respondents strongly agreed they would repeat treatment and recommend it to others [50-52].
dverse Effect Rates
ü Mild reactions (bruising and swelling): 25-35%
ü Discomfort during injection: up to 15%
ü Delayed nodules/granulomas: 1-2%
ü Serious complications (e.g., vascular occlusion): <0.5%
These numbers underscore that while minor side effects are common, serious events remain rare. However, their potential severity necessitates informed consent and preparedness to manage complications [53].
Correlates of Satisfaction and Complications
Cross-sectional data link several factors to outcomes:
ü Lower satisfaction and higher complication rates were noted among novice injectors and non-certified practitioners [54].
ü Patient age: Younger clients reported higher satisfaction, but older patients often experienced more swelling and slower healing.
ü Filler type: HA users experienced fewer complications and higher satisfaction than those treated with PLLA or PMMA [53-55].
The Best Practices to Enhance Satisfaction and Safety
Based on surveys and clinical evidence, the following strategies ae essential:
Thorough Pre-Treatment Assessment: Patient history, prior procedures, medications, and realistic expectation setting form the cornerstone of satisfaction outcomes.
Practitioner Training and Certification: Structured education dramatically reduces complication rates and boosts patient confidence.
Use of Imaging Technologies: Implementing ultrasound guidance reduces vascular risks and improves placement precision [56].
Safe Injection Techniques: Strategies such as aspiration before injection, slow administration, and low-volume boluses in high-risk zones are essential.
Detailed Aftercare Instructions: Patients should be counseled on managing temporary effects and alerted to signs of complications to ensure timely intervention [57].
Access to Expert Management Protocols: Clinics must have protocols and supplies (e.g., hyaluronidase and antibiotics) ready to manage acute and delayed complications [58-60].
Future Directions
Facial fillers, especially HA-based products, consistently deliver high patient satisfaction when administered by trained professionals under standardized protocols. Most adverse effects are mild and transient, though rare serious complications necessitate anatomical expertise and readiness to act [61-63].
Cross-sectional research highlights the importance of:
ü Skilled injectors.
ü Informed consent and expectation alignment.
ü Imaging guidance for safer placement.
Looking ahead, the field may evolve through:
ü Novel biodegradable and reversible filler formulations [64].
ü Integration of AI in treatment planning and photography [63-65].
ü Use of immersive consultations (e.g., 3D imaging) to manage expectations.
ü National registries to monitor satisfaction and long-term complications [66] (Table 2).
Table 2. Comparative table of common facial fillers [16].
|
Filler Type |
Main Substance |
Approximate Duration |
Reversibility |
Common Side Effects |
Severe Complications |
Patient Satisfaction (%) |
Notes |
|
Hyaluronic Acid (HA) |
Hyaluronic Acid |
6-18 months |
Yes (via hyaluronidase) |
Swelling, bruising, tenderness |
Vascular occlusion, rare blindness |
85-92% |
Most popular filler; high safety and reversibility |
|
Calcium Hydroxylapatite (CaHA) |
CaHA particles in gel |
12-18 months |
No |
Nodules, redness |
Granulomas, delayed infections |
75-85% |
Biostimulatory; used for deeper lines and volume loss |
|
Poly-L-lactic Acid (PLLA) |
Poly-L-lactic acid |
Up to 24 months |
No |
Swelling, lumps, redness |
Subcutaneous nodules |
70-80% |
Requires multiple sessions; gradual effect through collagen stimulation |
|
Polymethylmethacrylate (PMMA) |
PMMA microspheres |
Permanent |
No |
Hardening, nodules |
Chronic granulomas, tissue asymmetry |
60-70% |
Permanent filler; high risk of long-term complications |
|
Autologous Fat Transfer |
Patient’s own fat |
Variable (months to years) |
Partially |
Swelling, irregularities |
Fat necrosis, infection |
80-90% |
Natural-looking results; technique-dependent |
Conclusion
The use of facial fillers in aesthetic practice embodies a sophisticated balance of patient-centric care, technical skill, and risk management. High satisfaction rates, improved psychosocial functioning, and minimal downtime drive their continued demand. Yet, careful consideration of adverse effects, particularly regarding patient safety is concerned, remains critical.
Cross-sectional studies provide valuable insights into real-world experiences, reinforcing that patient education, thorough evaluation, and evidence-based protocols improve outcomes. As technologies and materials evolve, maintaining rigorous standards and embracing emerging evidence will ensure fillers remain safe, effective, and satisfying tools in aesthetic medicine.
Facial fillers have become indispensable in modern aesthetic practice, offering effective solutions for facial rejuvenation with minimal downtime. While patient satisfaction is generally high, attention to potential adverse effects and thorough patient management remains essential. Cross-sectional studies examining patient experiences provide important insights into optimizing outcomes and ensuring safety. As the field continues to evolve with new materials and techniques, ongoing research and education will be crucial in maintaining high standards of care.
While other filler types such as calcium hydroxylapatite (CaHA), Poly-L-lactic acid (PLLA), polymethylmethacrylate (PMMA), and autologous fat grafting provide longer-lasting or permanent results, they also present increased risks, such as granuloma formation, nodularity, or complications from incorrect placement. These risks underscore the importance of in-depth anatomical knowledge, proper injection technique, and thorough patient evaluation in aesthetic procedures.
The evidence reviewed in comparative studies shows that patient satisfaction is strongly linked to both the type of filler used and the clinician’s expertise. HA fillers, for example, show the highest satisfaction rates due to their flexibility and low complication rates. Autologous fat transfer, though technically demanding, also scores high when performed correctly. In contrast, permanent fillers like PMMA tend to have lower satisfaction levels due to their irreversible nature and potential for complications.
Furthermore, emerging technologies such as ultrasound-guided injections and a growing understanding of facial anatomy are enhancing the safety and precision of filler procedures. These advancements, along with increased focus on individualized treatment planning, have contributed to more natural and durable outcomes.
In conclusion, the choice of dermal filler must be specific to the patient, based on anatomical needs, desired longevity of results, risk tolerance, and budget considerations. Practitioners must stay abreast of filler science, new techniques, and complication management to ensure safety and optimal aesthetic outcomes. Future research should focus on long-term effects, ethnic and gender differences, and innovations in biocompatible filler materials to further improve the efficacy and safety of facial rejuvenation.
Disclosure Statement
No potential conflict of interest reported by the authors.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Authors' Contributions
All authors contributed to data analysis, drafting, and revising of the paper and agreed to be responsible for all the aspects of this work.